SURVYR

Compare funds

IBB×ARKG×
Facts side by side. Not investment advice.Compare stocks instead →
Still getting some data from the SEC and the price feed. This page refreshes by itself.

IBB and ARKG share 22 stocks, about 10% of IBB and 79% of ARKG (9.6% overlap by weight). Expense ratios: IBB 0.44%, ARKG 0.75%.

Holdings overlap
9.6%
by weight
Stocks in common
22
held by both
Expense ratio
IBB0.44%
ARKG0.75%
$31 a year apart on $10k

At a glance

Expense ratio = the yearly fee, as a share of your money in the fund. The lowest is marked.

IBBARKG
FundiShares Biotechnology ETFARK Genomic Revolution ETF
Expense ratio0.44%Lowest0.75%
Yearly cost on $10,000$44.00$75.00
Holdings24832
Top 10 holdings44.7%59.1%
Net assets$9.1B$1.6B
Holdings as ofJun 30, 2026Jul 31, 2026
Prospectus filedJul 27, 2026Nov 26, 2025

Past returns

Price change plus dividends. “Per year” rows are yearly averages. The highest in each row is in navy.

IBBARKG
1 week——
1 month——
3 months——
6 months——
Year to date——
1 year——
3 years, per year——
5 years, per year——
Since start of price data, per year——

Through —. A dash means the fund is younger than the period. Past returns don’t predict future returns.

Shared holdings

Largest first, by the smaller of the funds’ weights.

HoldingIBBARKG
Natera, Inc.NTRA
2.89%4.13%
Illumina, Inc.ILMN
2.07%4.74%
Ionis Pharmaceuticals, Inc.IONS
1.00%1.77%
Twist Bioscience Corp.TWST
0.48%7.73%
Tempus AI, Inc., Class ATEM
0.48%6.56%
CRISPR Therapeutics AGCRSP
0.38%6.29%
Veracyte, Inc.VCYT
0.36%2.55%
10X Genomics, Inc., Class ATXG
0.34%9.39%
Adaptive Biotechnologies Corp.ADPT
0.26%2.57%
Beam Therapeutics, Inc.BEAM
0.25%3.78%
Nurix Therapeutics, Inc.NRIX
0.19%2.51%
Intellia Therapeutics, Inc.NTLA
0.17%1.83%
Recursion Pharmaceuticals, Inc., Class ARXRX
0.13%2.63%
Ataibeckley IncATAI
0.12%0.76%
Absci Corp.ABSI
0.12%5.14%
Compass Pathways plcCMPS
0.12%3.25%
CareDx, Inc.CDNA
0.10%4.30%
Personalis, Inc.PSNL
0.06%5.47%
Pacific Biosciences of California, Inc.PACB
0.04%0.96%
Prime Medicine, Inc.PRME
0.03%1.41%

Top 20 of 22 shared holdings.

Only in IBB

217 holdings, 90.3% of the fund.

VRTX8.1%AMGN7.8%GILD6.8%REGN4.9%ARGX3.8%ALNY3.1%RVMD2.8%BIIB2.5%MRNA2.0%INSM1.8%ONC1.8%INCY1.7%

Only in ARKG

10 holdings, 20.5% of the fund.

GH4.7%LLY4.7%BFLY2.2%SDGR2.0%WGS1.9%ALMR1.6%GENB1.1%CERS1.0%MASS1.0%SCTX0.4%
How this works & disclosures

Holdings come from each fund’s latest public Form N-PORT on SEC EDGAR (as-of dates in the table), so they can be a few months old.

Expense ratios come from the fee table in each fund’s prospectus (Form 485BPOS) on SEC EDGAR, read from its XBRL data; a dash means it wasn’t machine-readable there, so check the prospectus. Yearly cost on $10,000 is simple arithmetic: expense ratio × $10,000, before any change in the fund’s value.

Returns use Yahoo Finance daily closes (15-min delayed source) adjusted for dividends and splits, so dividends are included as if reinvested. 3Y, 5Y and since-start figures are annualized (yearly averages). “Since start” begins on the first day our price source has for the fund; funds that started on different dates aren’t directly comparable. The growth chart is hypothetical, with no taxes or trading costs.

Overlap by weight adds up, for every holding both funds own, the smaller of its two weights. Shared stocks are matched by ticker, ISIN, CUSIP or name.

Data from SEC Form N-PORT, the holdings report funds file with the SEC each quarter; the SEC makes it public about 60 days after the quarter ends. Holdings change; this may be out of date. SURVYR. describes what funds hold and how they have done; it does not manage money or give advice. Not investment advice. Full disclosures

Data from SEC filings. Holdings change; this may be out of date. Not investment advice. Disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026